4//SEC Filing
SCHMIDT ERIC THOMAS 4
Accession 0001214659-22-004371
CIK 0001737287other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 5:49 PM ET
Size
7.8 KB
Accession
0001214659-22-004371
Insider Transaction Report
Form 4
SCHMIDT ERIC THOMAS
Chief Financial Officer
Transactions
- Award
Common Stock
2022-03-23+237,358→ 337,904 total - Award
Stock Option (Right to Buy)
2022-03-23+368,589→ 368,589 totalExercise: $9.69Exp: 2032-03-23→ Common Stock (368,589 underlying)
Holdings
- 1,152,595(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter
- [F2]The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001754403
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 5:49 PM ET
- Size
- 7.8 KB